Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis

Digestive Diseases and Sciences

Volumn 41, Issue 11, 1996, Pages 2219-2221

  Cicognani, Camilla ^a   Malavolti, Mauro ^a   Morselli Labate, Antonio Maria ^a   Sama, Claudia ^a   Barbara, Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Drug induced hepatitis; Flutamide; Ursodeoxycholic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FLUTAMIDE; GONADORELIN DERIVATIVE; LEUPRORELIN; URSODEOXYCHOLIC ACID;

AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTATE CANCER; TOXIC HEPATITIS;

EID: 0029807157     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02071403     Document Type: Article

References (26)

1. McLeod DG: Antiandrogenic drugs. Cancer 71:1046-1049, 1993
2. Lund F, Rasmussen F: Flutamide versus stiboestrol in the management of advanced prostatic cancer. Br J Urol 61:140-142, 1988
3. Crowford ED, Eisenberger MA, McLeod DG, Spaulding JT, Benson R, Dorr FA, Blumenstein BA, Davis MA, Goodman PJ: A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 321:419-424, 1989
4. Gomez JL, Dupont A, Cusan L, Tremblay M, Suburu R, Lemay J, Labrie F: Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Am J Med 92:465-470, 1992
5. Wysowski D, Freiman JP, Tourtelot JB, Horton ML: Fatal and nonfatal hepatotoxicity associated with flutamide. Ann Intern Med 118:860-864, 1993
6. Robinson MRG, Denis L, Newling DWW, Sylvester R, De Pauw MM: EORTC protocol 30853: Orchidectomy versus zoladex plus flutamide in the management of metastatic carcinoma of the prostate. Cancer 66:1022-1024, 1990
7. Møller S, Iversen P, Franzmann MB: Flutamide-induced liver failure. J Hepatol 10:346-349, 1990
8. Rosman AS, Frissora-Rodeo C, Marshall AT, Reiter BP, Paronetto F: Cholestatic hepatitis following flutamide. Dig Dis Sci 38:1756-1759, 1993
9. Hart W, Stricker BH: Flutamide and hepatitis. Ann Intern Med 110:943-944, 1989 (letter)
10. Corkery JC, Bihrle W, McCaffrey JA, Whitcomb FF, Levy C, Ellis R: Flutamide-related fulminant hepatic failure. J Clin Gastroenterol 13:364-365, 1991
11. Dourakis SP, Alexopolou AA, Hadziyannis SJ: Fulminant hepatitis after flutamide treatment. J Hepatol 20:350-353, 1994
12. Coppere H, Perraud Y, Gerard F, Jouffre C, David A, Barthelemy C, Audigier JC: Un cas d'hepatite aigue au flutamide. Gastroenterol Clin Biol 14:105-106, 1990
13. Sogani P, Vagaiwala M, Witmore W: Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy. Cancer 54:744-750, 1984
14. Alperine M, Cohen L, Cocheton JJ, Lecomte I, Meyniel D: Hepatite aigue due au flutamide. Press Med 10:1459-1460, 1991
15. Fromm H: Gallstone dissolution and the cholesterol-bile acid-lipoprotein axis. Propitious effects of ursodeoxycholic acid. Gastroenterology 87:229-233, 1984
16. Salen G, Tint GS, Shefer S: Oral dissolution treatment of gallstones with bile acids. Semin Liv Dis 10:181-186, 1990
17. Poupon RE, Chretien Y, Poupon R, Paumgartner G: Serum bile acid in primary biliary cirrhosis: Effect of ursodeoxycholic acid therapy. Hepatology 17 (4): 599-604, 1993
18. O'Brien CB, Senior JR, Arona-Mirchandani R, Batta A, Salen G: Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: A 30-month pilot study: Hepatology 14:838-847, 1991
19. Podda M, Ghezzi C, Battezzati PM, Crosignani A, Zuin M, Roda A: Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis. Gastroenterology 98:1044-1050, 1990
20. Palma J, Reyes H, Ribalta J, Iglesias J, Gonzalez MC, Hernandez I, Alvarez C, Molina C, Danitz AM: Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 15:1043-1047, 1992
21. Friman S, Persson H, Schersten T, Svanvik J, Karlberg I: Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver transplantation. Transplant Proc 24:389-390, 1992
22. Reichen J: Treatment of cholestasis. Semin Liv Dis 13:302-315, 1993
23. Kallinowski B, Theilmann L, Zimmermann R, Gams E, Kommerell B, Stiehl A: Effective treatment of cyclosporine-induced cholestasis in heart-transplanted patients treated with ursodeoxycholic acid. Transplantion 51:1128-1129, 1991
24. Friedman A, Norcross MJ, Rein M: Adverse effects of leuprolide acetate depot treatment. Fertil Steril 59:448-450, 1993
25. Queneau PE, Bertault-Peres P, Guitaoni M, Mesdjian E, Durand A, Montet JC: Improvement of cyclosporin A-induced cholestasis by tauroursodeoxycholate in a long-term study in the rat. Dig Dis Sci 39:1581-1585, 1994
26. Güldütuna S, Zimmer G, Imhof M, Bhatti S, Tiangeng Y, Leuschner U: Molecular aspects of membrane stabilization by ursodeoxycholate. Gastroenterology 104:1736-1744, 1993